• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The KIF5B-RET Fusion Gene Mutation as a Novel Mechanism of Acquired EGFR Tyrosine Kinase Inhibitor Resistance in Lung Adenocarcinoma.

作者信息

Zhu You-Cai, Wang Wen-Xian, Zhang Qu-Xia, Xu Chun-Wei, Zhuang Wu, Du Kai-Qi, Chen Gang, Lv Tang-Feng, Song Yong

机构信息

Department of Thoracic Disease Diagnosis and Treatment Center, Zhejiang Rongjun Hospital, Jiaxing Zhejiang, People's Republic of China.

Department of Chemotherapy, Zhejiang Cancer Hospital, Hangzhou Zhejiang, People's Republic of China.

出版信息

Clin Lung Cancer. 2019 Jan;20(1):e73-e76. doi: 10.1016/j.cllc.2018.09.011. Epub 2018 Sep 21.

DOI:10.1016/j.cllc.2018.09.011
PMID:30366769
Abstract
摘要

相似文献

1
The KIF5B-RET Fusion Gene Mutation as a Novel Mechanism of Acquired EGFR Tyrosine Kinase Inhibitor Resistance in Lung Adenocarcinoma.KIF5B-RET融合基因突变作为肺腺癌获得性表皮生长因子受体酪氨酸激酶抑制剂耐药的新机制
Clin Lung Cancer. 2019 Jan;20(1):e73-e76. doi: 10.1016/j.cllc.2018.09.011. Epub 2018 Sep 21.
2
[The progress of KIF5B-RET fusion gene in non-small cell lung cancer].[KIF5B-RET融合基因在非小细胞肺癌中的研究进展]
Zhonghua Jie He He Hu Xi Za Zhi. 2013 Jul;36(7):524-6.
3
Clinical and prognostic implications of RET rearrangements in metastatic lung adenocarcinoma patients with malignant pleural effusion.RET重排在伴有恶性胸腔积液的转移性肺腺癌患者中的临床及预后意义
Lung Cancer. 2015 May;88(2):208-14. doi: 10.1016/j.lungcan.2015.02.018. Epub 2015 Mar 4.
4
A phase 2 study of lenvatinib in patients with RET fusion-positive lung adenocarcinoma.一项评估 lenvatinib 治疗 RET 融合阳性肺腺癌患者的 2 期研究。
Lung Cancer. 2019 Dec;138:124-130. doi: 10.1016/j.lungcan.2019.09.011. Epub 2019 Sep 16.
5
Diagnostic method for the detection of KIF5B-RET transformation in lung adenocarcinoma.肺腺癌中 KIF5B-RET 转化的检测诊断方法。
Lung Cancer. 2013 Oct;82(1):44-50. doi: 10.1016/j.lungcan.2013.07.009. Epub 2013 Aug 9.
6
Developments for Personalized Medicine of Lung Cancer Subtypes: Mass Spectrometry-Based Clinical Proteogenomic Analysis of Oncogenic Mutations.肺癌亚型个性化医疗的进展：基于质谱的致癌突变临床蛋白质基因组分析
Adv Exp Med Biol. 2016;926:115-137. doi: 10.1007/978-3-319-42316-6_8.
7
Lung adenocarcinoma harboring concomitant EGFR mutation and EML4-ALK fusion that benefits from three kinds of tyrosine kinase inhibitors: a case report and literature review.携带EGFR突变和EML4-ALK融合且受益于三种酪氨酸激酶抑制剂的肺腺癌：病例报告及文献综述
Clin Lung Cancer. 2015 Mar;16(2):e5-9. doi: 10.1016/j.cllc.2014.11.001. Epub 2014 Nov 18.
8
KIF5B-RET fusions in lung adenocarcinoma.肺腺癌中的 KIF5B-RET 融合。
Nat Med. 2012 Feb 12;18(3):375-7. doi: 10.1038/nm.2644.
9
A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing.全基因组和转录组测序揭示肺腺癌中存在一个转化的 KIF5B 和 RET 基因融合。
Genome Res. 2012 Mar;22(3):436-45. doi: 10.1101/gr.133645.111. Epub 2011 Dec 22.
10
Detection of RET (rearranged during transfection) variants and their downstream signal molecules in RET rearranged lung adenocarcinoma patients.在RET重排的肺腺癌患者中检测RET（转染期间重排）变异及其下游信号分子。
Surg Oncol. 2018 Mar;27(1):106-113. doi: 10.1016/j.suronc.2018.01.006. Epub 2018 Feb 8.

引用本文的文献

1
Comprehensive next-generation sequencing reveals double primary colorectal carcinoma missed by diagnostic imaging: A case report.全面的二代测序揭示诊断性影像学漏诊的双原发性结直肠癌：一例报告
World J Gastrointest Oncol. 2023 Oct 15;15(10):1823-1828. doi: 10.4251/wjgo.v15.i10.1823.
2
Response to Pralsetinib Observed in Meningeal-Metastatic -Mutant NSCLC With Acquired Fusion: A Brief Report.在获得性RET融合的脑膜转移RET突变型非小细胞肺癌中观察到的普拉替尼反应：简要报告
JTO Clin Res Rep. 2022 May 19;3(6):100343. doi: 10.1016/j.jtocrr.2022.100343. eCollection 2022 Jun.
3
The potential and limitation of targeted chromosomal breakpoint sequencing for the fusion gene identification in lung cancer.
靶向染色体断点测序在肺癌融合基因鉴定中的潜力与局限性
Am J Cancer Res. 2022 May 15;12(5):2376-2386. eCollection 2022.
4
The Landscape of Novel Expressed Chimeric RNAs in Rheumatoid Arthritis.类风湿关节炎中新表达嵌合 RNA 的研究现状。
Cells. 2022 Mar 24;11(7):1092. doi: 10.3390/cells11071092.
5
Emerging a Novel VOPP1-EGFR Fusion Coexistent With T790M as an Acquired Resistance Mechanism to Prior Icotinib and Sensitive to Osimertinib in a Patient With EGFR L858R Lung Adenocarcinoma: A Case Report.在一名EGFR L858R肺腺癌患者中出现一种新型的VOPP1-EGFR融合基因与T790M共存，作为对先前埃克替尼的获得性耐药机制且对奥希替尼敏感：一例报告
Front Oncol. 2021 Dec 22;11:720819. doi: 10.3389/fonc.2021.720819. eCollection 2021.
6
Fusion: Joining the Ranks of Targetable Molecular Drivers in NSCLC.融合：跻身非小细胞肺癌中可靶向分子驱动因素之列
JTO Clin Res Rep. 2020 May 13;1(3):100050. doi: 10.1016/j.jtocrr.2020.100050. eCollection 2020 Sep.
7
Genomic characterization and outcome evaluation of kinome fusions in lung cancer revealed novel druggable fusions.肺癌激酶组融合的基因组特征及预后评估揭示了新的可靶向治疗的融合基因。
NPJ Precis Oncol. 2021 Sep 10;5(1):81. doi: 10.1038/s41698-021-00221-z.
8
Emerging Role of Chimeric RNAs in Cell Plasticity and Adaptive Evolution of Cancer Cells.嵌合RNA在癌细胞可塑性和适应性进化中的新作用。
Cancers (Basel). 2021 Aug 27;13(17):4328. doi: 10.3390/cancers13174328.
9
An autophagy-related model of 4 key genes for predicting prognosis of patients with laryngeal cancer.一种用于预测喉癌患者预后的4个关键基因的自噬相关模型。
Medicine (Baltimore). 2020 Jul 24;99(30):e21163. doi: 10.1097/MD.0000000000021163.